Literature DB >> 3849977

Presence of normal human cell surface antigens in plasma of athymic mice bearing a human colon carcinoma and in normal human plasma.

Y Markson, D W Weiss, O Weiss, F Doljanski.   

Abstract

The mixed haemadsorption (MHA) method was employed for detection of several normal antigenic components on the surface of human colon carcinoma cells (HT-29). The antigens were expressed by cells in monolayer cultures and in suspensions prepared by monolayer trypsinization, and by cells of tumours growing progressively in athymic mice. The plasma of such animals bearing medium sized and large, non-necrotic tumours contained all the antigens, as determined by the radial diffusion immune haemolysis method (RDIH); the plasma of animals with small or large heavily necrotic tumours did not contain detectable amounts of any of the determinants. The half-life of the determinants in the circulation as extracellular entities was ca. 20 h. The same antigens, and fibronectin, were found to be ubiquitously represented in normal human plasma. It is proposed that the presence of membrane antigens in plasma is the result of physiological shedding of cell surface constituents by living cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3849977     DOI: 10.1007/bf00205679

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

Review 1.  Human cancer-associated antigens: present status and implications for immunodiagnosis.

Authors:  D Sulitzeanu
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Shedding of histocompatibility and blood group antigenic determinants from human epithelial cells and fibroblasts in culture.

Authors:  Y M Plesser; Y Markson; D W Weiss; C Brautbar; F Doljanski
Journal:  Cell Mol Biol       Date:  1983       Impact factor: 1.770

Review 3.  Shedding from the cell surface of normal and cancer cells.

Authors:  P H Black
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

4.  Cell-surface shedding by fibroblasts in culture.

Authors:  Y M Plesser; D W Weiss; F Doljanski
Journal:  Isr J Med Sci       Date:  1980-07

5.  Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.

Authors:  A H Ross; M Herlyn; C S Ernst; D Guerry; J Bennicelli; B F Ghrist; B Atkinson; H Koprowski
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

7.  Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.

Authors:  P Giacomini; F Veglia; P Cordiali Fei; T Rehle; P G Natali; S Ferrone
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

8.  Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer.

Authors:  J Burchell; D Wang; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1984-12-15       Impact factor: 7.396

9.  Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model.

Authors:  K W Martin; S E Halpern
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

10.  Antibody response of nude (RNU/RNU) and hairy (RNU/+) rats to circulating cell surface components from human pancreatic cancer xenografts.

Authors:  G Davies; A G Grant; D Duke; J Hermon-Taylor
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.